South American Pricing Coalition Sets Sights On Alexion’s Soliris and Monoclonal Antibodies
A South American pricing coalition that includes Brazil, Venezuela and Argentina has announced plans to buy high-cost drugs, such as eculizumab (Alexion’s Soliris).
You may also be interested in...
Strengthening Brazil’s policy on orphan drugs would help stem the number of court cases brought by patients to access medicines, says Alexion.
Pooled procurement will not fix problems relating to affordability and access to medicines in South America, says the US pharma industry association, PhRMA, in response to news that Mercosur trade bloc members will join forces to negotiate better prices for medicines.
Another alliance among EU countries to tackle high medicines prices is gathering pace. Eight countries are to soon start swapping pricing information and have agreed to join forces to negotiate more affordable prices.